• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

The recent advances in technology combined with the need to manage patients remotely
during the coronavirus disease-19 (COVID-19) pandemic, have led to a rapid adaptation of …

Background: Low detection and nonadherence are major problems in current management
approaches for patients with suspected atrial fibrillation (AF). Mobile health devices may …

Background Current management of patients with atrial fibrillation (AF) is limited by low
detection of AF, non-adherence to guidelines, and lack of consideration of patients' …

Aims Atrial fibrillation (AF) is the most common sustained heart arrhythmia and a major
preventable cause of stroke, heart failure, and dementia. Atrial fibrillation already accounts …

As the most prevalent form of arrhythmia, atrial fibrillation (AF) increases the risk of heart
failure, thromboembolism, and stroke, contributing to the raising mortality and morbidity in …

Abstract Background. In the mobile Atrial Fibrillation App (mAFA)-II trial, the use of mobile
health (mHealth) technology, incorporating AF screening and integrated management …

Atrial fibrillation (AF) is the most common clinical arrhythmia with substantial health and
socioeconomic impact on healthcare. 1 The number of people affected by this condition was …